1
/
of
0
FDA Drug Approval, N018892, SODIUM PHOSPHATES IN PLASTIC CONTAINER
FDA Drug Approval, N018892, SODIUM PHOSPHATES IN PLASTIC CONTAINER
Regular price
$49.00 USD
Regular price
Sale price
$49.00 USD
Unit price
/
per
NDA: 018892
Company: HOSPIRA
Drug Name: SODIUM PHOSPHATES IN PLASTIC CONTAINER
Active Ingredients: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AP
Submission Classification: STANDARD
Company: HOSPIRA
Drug Name: SODIUM PHOSPHATES IN PLASTIC CONTAINER
Active Ingredients: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AP
Submission Classification: STANDARD
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details